169 related articles for article (PubMed ID: 3161481)
21. Cardiovascular effects of buprenorphine in anesthetized dogs.
Martinez EA; Hartsfield SM; Melendez LD; Matthews NS; Slater MR
Am J Vet Res; 1997 Nov; 58(11):1280-4. PubMed ID: 9361893
[TBL] [Abstract][Full Text] [Related]
22. [Effects of recombinant human brain natriuretic peptide and milrinone on cardiac hemodynamics and renal function in anesthetized dog].
Xu XW; Yang W; Zhao ZY; Liu HX; Zeng GY
Yao Xue Xue Bao; 2002 Jul; 37(7):506-9. PubMed ID: 12914318
[TBL] [Abstract][Full Text] [Related]
23. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
[TBL] [Abstract][Full Text] [Related]
24. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
25. [Hemodynamic effects of induced hypotension by ketanserin in anesthetized dogs].
Takeda S; Matsui K; Inada Y; Nakamizo N; Ikeda T; Tomaru T
Masui; 1992 Apr; 41(4):611-8. PubMed ID: 1578617
[TBL] [Abstract][Full Text] [Related]
26. [Influence of an antispastic, analgesic combination on blood pressure, dynamics and contractility of the left ventricle in the dog].
Komarek J
Arzneimittelforschung; 1976; 26(8):1583-8. PubMed ID: 1036957
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
[TBL] [Abstract][Full Text] [Related]
28. [Effects of diltiazem on cardiac function in the dog (author's transl)].
Narita H; Ikezawa K; Sato M; Nakajima H; Kiyomoto A
Nihon Yakurigaku Zasshi; 1981 Jan; 77(1):51-9. PubMed ID: 7262707
[TBL] [Abstract][Full Text] [Related]
29. Effects of nipradilol (K-351) on cardiac function in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Takeo S; Ito H; Miyamoto Y; Kato T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):47-55. PubMed ID: 2861795
[TBL] [Abstract][Full Text] [Related]
30. Fantofarone (SR 33557): cardiovascular actions in anesthetized dogs.
Barthélémy G; Chatelain P; Manning A
Arch Int Pharmacodyn Ther; 1994; 327(2):204-19. PubMed ID: 7979829
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
Bolt GR; Saxena PR
Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
Woodman OL; Vatner SF
J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
[TBL] [Abstract][Full Text] [Related]
33. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
[TBL] [Abstract][Full Text] [Related]
34. Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failure.
Grobecker H; Gessler I; Delius W; Dominiak P; Kees F
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S102-4. PubMed ID: 2412024
[TBL] [Abstract][Full Text] [Related]
35. 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats.
Connor HE; Feniuk W; Humphrey PP; Perren MJ
Br J Pharmacol; 1986 Feb; 87(2):417-26. PubMed ID: 2937503
[TBL] [Abstract][Full Text] [Related]
36. Antagonism of the 5-HT-induced bronchoconstriction in the cat.
Reiche R; Frey HH
Arch Int Pharmacodyn Ther; 1983 May; 263(1):139-45. PubMed ID: 6615080
[TBL] [Abstract][Full Text] [Related]
37. Effects of serotonin inhibition in air embolism in dogs.
Vincent JL; Goldstein J; Domb M; Lignan H
Eur Surg Res; 1988; 20(3):175-80. PubMed ID: 3402512
[TBL] [Abstract][Full Text] [Related]
38. Serotonergic mechanisms and blood pressure in sheep.
Nelson MA; Coghlan JP; Denton DA; Mills EH; Scoggins BA; Spence CD; Whitworth JA
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S117-9. PubMed ID: 2412029
[TBL] [Abstract][Full Text] [Related]
39. The central action of the 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on cardiac inotropy and vascular resistance in the anaesthetized cat.
Ramage AG; Daly MB
Br J Pharmacol; 1998 Nov; 125(6):1172-9. PubMed ID: 9863644
[TBL] [Abstract][Full Text] [Related]
40. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction.
Meuleman TR; Hill DC; Port JD; Stanley TH; Pace NL; Mohammad SF
Crit Care Med; 1983 Aug; 11(8):606-11. PubMed ID: 6872549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
